DeutschNewstral
Article
kfor.com on 2019-10-22 18:56
Drugmaker reverses course, plans to seek FDA approval for Alzheimer’s treatment
Related news
Durham drugmaker preps for commercialization as it awaits FDA approvalbizjournals.com
Over-the-counter birth control? Drugmaker seeks FDA approvallasvegassun.com- Durham drugmaker secures its first FDA approval, pivots to commercializationbizjournals.com
FDA Reverses Broad Approval For Controversial Alzheimer's DrugForbes- TFDA argues public harm if court reverses abortion pill approvalthehill.com
FDA delays action on promising Alzheimer’s drug donanemab, drugmaker Eli Lilly saysUSA today
First new Alzheimer’s drug in decades receives controversial FDA approvalnewatlas.com
Eli Lilly applies for FDA approval on Alzheimer’s drugnwaonline.com
House investigation faults FDA, Biogen for Alzheimer’s drug approvalpost-gazette.com
FDA calls for federal investigation into approval of Alzheimer’s drugNew York Post
Alzheimer’s drug approval by FDA ‘rife with irregularities,’ probe findsLA Times
Biogen Submits Promising Alzheimer’s Drug Aducanumab to FDA for Approvalobserver.com- BSigns Point to FDA Approval for Biogen’s Alzheimer’s Drugbarrons.com
- BSarepta Stock Is Spiking as FDA Reverses Course, Approving Drugbarrons.com
- With positive trial data in hand, Durham drugmaker looks ahead to FDA approvalbizjournals.com
Trump Does Informercial for Experimental Coronavirus Drug as Drugmaker Requests Emergency FDA Approvalslate.com
FDA reverses itself, calls for limiting use of contentious Alzheimer’s drug amid backlashpressherald.com
Appeals court reverses Texas ruling nullifying FDA approval of abortion pillArs Technica
FDA head calls for investigation into agency approval of Alzheimer’s drugAlaska Dispatch News